Engineering and design software provider PTC (NASDAQ:PTC) reported Q4 CY2024 results beating Wall Street’s revenue ...

Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

Below is Validea's guru fundamental report for PTC INC (PTC). Of the 22 guru strategies we follow, PTC rates highest using our P/B Growth Investor model based on the published strategy of Partha ...

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Cantor Fitzgerald's analysts demonstrated a positive outlook on PTC Therapeutics (NASDAQ:PTCT), increasing the price target to $113.00 from the previous $76.00. The firm maintains an Overweight rating ...

Nasdaq 100 E-Mini futures (NQH25) are trending down -0.91% this morning as disappointing results from Alphabet and Advanced ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced that the primary endpoint was achieved in the APHENITY, Phase 3 registration-directed clinical trial of sepiapterin in adult ...